TITLE
Multiple sclerosis response to interferon beta-1a therapy: peripheral blood mononuclear cells

SUMMARY
Analysis of peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis (MS) patients 1 day before, 1 day after, and up to 12 months after the initiation of interferon beta-1a (IFN-beta-1a) therapy. Results identify biomarkers for beta-IFN responsiveness.

ORGANISM
Homo sapiens

PLATFORM
GPL4191 : CodeLink UniSet Human I Bioarray

CITATIONS
Singh MK, Scott TF, LaFramboise WA, Hu FZ et al. Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy. J Neurol Sci 2007 Jul 15;258(1-2):52-9. PMID:Â  17467740

